Disease Overview：Upper Airway Cough Syndrome（UACS）
Upper Airway Cough Syndrome (UACS), formerly known as postnasal drip syndrome, is a common chronic cough etiology characterized by persistent cough lasting more than eight weeks, primarily driven by rhinosinusitis, allergic or non-allergic rhinitis, or nasal polyposis. Symptoms include throat clearing, sensation of mucus dripping into the pharynx, nasal congestion, and often concomitant laryngeal irritation—without evidence of asthma, gastroesophageal reflux disease, or chronic bronchitis on objective evaluation. Diagnosis relies on clinical assessment, nasolaryngoscopy, sinonasal imaging (e.g., CT of sinuses), and response to empirical therapy such as intranasal corticosteroids and second-generation antihistamines. When refractory, targeted interventions—including image-guided endoscopic sinus surgery or biologic therapies for eosinophilic inflammation—may be indicated.
China offers distinct advantages in UACS management: leading respiratory centers—such as Peking Union Medical College Hospital and Shanghai Ruijin Hospital—employ multidisciplinary teams with deep expertise in airway immunology and functional endoscopic sinus surgery. Advanced diagnostic tools, including high-resolution CT, acoustic rhinometry, and mucociliary clearance testing, support precise phenotyping. Clinical outcomes reflect high success rates, particularly in complex cases involving comorbid chronic rhinosinusitis with nasal polyps. Treatment costs in China are typically 40–60% lower than in the US or Western Europe, without compromising evidence-based protocols or accreditation standards (JCI- or CNAS-certified facilities). As a dedicated medical tourism agency, we facilitate seamless international patient journeys—handling hospital referrals, coordinating pre-arrival diagnostics, ensuring transparent all-inclusive pricing, and providing end-to-end support from visa assistance to post-treatment follow-up.
Upper Airway Cough Syndrome: treatment in China helps patients compare specialist hospitals, initial assessment steps and estimated costs that may vary by city, institution and clinical condition.
Medical Treatment Guide
Treatment Options & Itemized Cost Breakdown: Upper Airway Cough Syndrome (UACS)
Non-Surgical / Conservative / Medication Options
*Target Criteria:* Confirmed UACS diagnosis (postnasal drip, nasal congestion, throat clearing; negative asthma/COPD workup; symptom improvement with nasal corticosteroids).
- •First-Line Therapy (Tier 1)
- Second-generation oral antihistamine (loratadine 10 mg OD): ¥25–¥42/month ($4–$6) - Saline nasal irrigation kit + isotonic solution (30-day supply): ¥32–¥58 ($5–$8) - *Initial diagnostic workup*: Nasal endoscopy (in-office), basic allergy screening (IgE + 5 common aeroallergens): ¥390–¥520 ($55–$73)
- •Second-Line Therapy (Tier 2)
- Leukotriene receptor antagonist (montelukast 10 mg OD): ¥85–¥130/month ($12–$18) - *Add-on diagnostics*: Sinus CT (non-contrast, limited protocol): ¥480–¥650 ($67–$91)
Surgical / Procedural / Interventional Options
*Eligibility Criteria:* Chronic (>12 weeks), refractory UACS with objective evidence of structural pathology (e.g., concha bullosa, deviated septum, chronic sinusitis on CT/endoscopy) unresponsive to ≥3 months of maximal medical therapy.
- •Functional Endoscopic Sinus Surgery (FESS)
- Bilateral FESS + septoplasty: ¥18,200–¥23,600 ($2,550–$3,300) - *Preoperative workup*: ECG, chest X-ray, coagulation panel, pre-anesthesia assessment: ¥620–¥890 ($87–$125)
- •Radiofrequency Turbinate Reduction (RFR)
- *Preoperative workup*: Same as above (¥620–¥890 / $87–$125)
Special / Complex Condition Options
- •UACS with GERD overlap: 8-week PPI trial (esomeprazole 40 mg OD) + pH-impedance monitoring: ¥1,250–¥1,680 ($175–$235)
- •UACS in elderly (>75 yrs) with polypharmacy: Geriatric pharmacotherapy review + dose-adjusted nasal steroid (ciclesonide): ¥320 consultation ($45)
- •Pediatric UACS (<12 yrs): Pediatric ENT evaluation + age-specific nasal spray training: ¥480–¥650 ($67–$91)
Quick Selection Guide
- •Mild-moderate adult (budget-conscious): Tier 1 meds + saline irrigation ($27–$40/month); avoid imaging unless no response at 4 weeks.
- •Severe refractory adult (no comorbidities): Proceed to sinus CT → FESS if structural disease confirmed ($2,640–$3,430 total).
- •Elderly patient with hypertension/diabetes: Prioritize low-dose intranasal ciclesonide + RFR over systemic steroids or major surgery ($1,100–$1,350 total).
- •Child with recurrent UACS: Pediatric ENT consult + allergen avoidance strategy before medication ($67–$91 initial cost).
Pricing & Service Differences: International / VIP Dept vs. Regular Clinic
International Medical Services (IMS / VIP Departments) at Grade-3A public hospitals and private international clinics operate under self-regulated VIP fee schedules. Fees are higher than standard public clinics (which are subsidized solely for domestic citizens and do not accept overseas insurances). In exchange, international patients receive 6 exclusive medical privileges:
Recommended Hospitals
Explore selected Grade 3A public hospitals in China with rich clinical experience for this condition:
🌴 Recommended Upper Airway Cough Syndrome Medical Vacation Packages
Curated transparent all-inclusive packages combining Upper Airway Cough Syndrome treatment with China top medical destinations:
